Fermented Foods and the Gut–Liver Axis: Modulation of MASLD Through Gut Microbiota
Nutrients · 2026
DOI: 10.3390/nu18030542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Agnieszka Wesołek-Leszczyńska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obesity Treatment, Metabolic Disorders, and Clinical Dietetics, Poznan University of Medical Sciences, 60-569 Poznań, Poland. Hauptthemen laut MEDLINE: Liver, Gastrointestinal Microbiome, Fermented Foods, Fatty Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a prevalent condition defined by hepatic fat accumulation, inflammation, and metabolic dysregulation. Current evidence demonstrates that gut microbiota and their metabolites are associated with MASLD pathogenesis. Fermented foods, rich in live microbes and bioactive compounds, actively modulate the gut–liver axis and influence disease progression. This narrative review provides a comprehensive summary of current evidence on the impact of fermented foods on gut microbiota, intestinal barrier function, and gut–liver interactions, and demonstrates their potential role in preventing or mitigating MASLD.
Methods
A comprehensive literature search of preclinical and clinical studies was conducted. Specifically, the review focused on fermented-food interventions, modulation of gut microbiota, metabolite production, and effects on hepatic metabolism and inflammation.
Results
This review found that fermented foods provide probiotics, prebiotics, short-chain fatty acid (SCFAs), and bioactive compounds that enhance microbial diversity, improve intestinal barrier integrity, reduce endotoxemia, and modulate bile acid and lipid metabolism. Evidence from animal and human studies indicates that fermented food consumption can attenuate hepatic steatosis, inflammation, and metabolic dysregulation, with variability depending on individual microbiome composition.
Conclusions
Altogether, these findings suggest that fermented foods represent a promising adjunctive dietary strategy for MASLD by modulating the gut–liver axis and supporting metabolic and hepatic health. Personalized approaches and further long-term clinical trials are required to optimize interventions and establish evidence-based recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obesity Treatment, Metabolic Disorders, and Clinical Dietetics, Poznan University of Medical Sciences, 60-569 Poznań, Poland.
- Doctoral School, Poznan University of Medical Sciences, 60-569 Poznań, Poland.
- Medical Education, Wroclaw Medical University, 50-367 Wroclaw, Poland.
ORCID-Profile: Agnieszka Wesołek-Leszczyńska, Dawid Rosiejka, Kalina Bogdańska, Paweł Bogdański
Zitieren
APA
Wesołek-Leszczyńska, A., Rosiejka, D., Bogdańska, K., & Bogdański, P. (2026). Fermented Foods and the Gut–Liver Axis: Modulation of MASLD Through Gut Microbiota. Nutrients. https://doi.org/10.3390/nu18030542
Vancouver
Wesołek-Leszczyńska A, Rosiejka D, Bogdańska K, Bogdański P. Fermented Foods and the Gut–Liver Axis: Modulation of MASLD Through Gut Microbiota. Nutrients. 2026. doi:10.3390/nu18030542
BibTeX
@article{WesoekLeszczyska2026,
author = {Wesołek-Leszczyńska, Agnieszka and Rosiejka, Dawid and Bogdańska, Kalina and Bogdański, Paweł},
title = {Fermented Foods and the Gut–Liver Axis: Modulation of MASLD Through Gut Microbiota},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18030542}
}
EUVIMED